Please assess the completion status of the following clinical trial:

Trial Title: Description of Physical Activity Effect on Neuromuscular Fatigue of Older People

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 to 35 for the young group, between 65 and 80 for the old group and over 80 for the very old group.~* Signed consent for the study obtained~* Subject affiliated or entitled to a social security scheme~Exclusion Criteria:~* Pathology or surgical intervention causing a locomotor disorder~* Neurological, cardiovascular or psychological pathology~* Participants will be excluded if resting or exercise ECG responses show any abnormality, or if resting Heart Rate (HR) \> 100 bmp, resting blood pressure \> 144 (systolic) / 95 (diastolic) mmHg, pulmonary and or cardiac disease that could affect the health of the participant (arrhythmias and stroke)~* Mini-Mental State Examination score \< 20 (\>80 years old)~* Significant change in the amount of physical practice over the last 5 years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Young, Active group (Type: ACTIVE_COMPARATOR): From 18 to 35 years old.~The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:~* at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR~* at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR~* At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 Metabolic Equivalent of Task (MET)-minutes per week
- Young, sedentary group (Type: ACTIVE_COMPARATOR): From 18 to 35 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
- Old, Active group (Type: ACTIVE_COMPARATOR): From 65 to 80 years old.~The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:~* at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR~* at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR~* At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 MET-minutes per week
- Old sedentary group (Type: ACTIVE_COMPARATOR): From 65 to 80 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
- Very old, Active group (Type: ACTIVE_COMPARATOR): From 81 years old.~The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:~* at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR~* at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR~* At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 MET-minutes per week
- Very old sedentary group (Type: ACTIVE_COMPARATOR): From 81 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.

Based on this trial design, predict the completion outcome and termination type (if applicable).